FDA-Drug2026-10-14Class IICHEMICAL
Preferred Pharmaceuticals Lidocaine Ointment USP 5% recalled for failed content uniformity
What this means
Preferred Pharmaceuticals' Lidocaine Ointment USP 5% (generic Xylocaine) in 50 g jars failed to meet content uniformity specifications, meaning the active ingredient may not be evenly distributed throughout the product. This affects four specific lots with expiration dates of April 30, 2027. No injuries have been reported.
- Check your prescription bottles for lot numbers F1925G, E0925T, D3025M, or D0825D.
- Do not use the product if you have one of the affected lots.
- Contact your pharmacist or doctor for a replacement or alternative treatment.
The agency's original wording
Hazard
Failed Content Uniformity Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
USA Nationwide
Affected count
N/A
Manufactured in
1250 N Lakeview Ave Ste O, N/A, Anaheim, CA, United States
Products
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0013-2027Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.